2SL-27880-70396
3 vaccinations
4 coded responses
40 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 730 / OK
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
-
2021-01-04
Survey response — day 14, dose 1MedDRA: Cough — Feeling: GoodFree text: Very mile cough just on evening of 1/2/21 and again on 1/3/21 evening; resolved today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-11
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
-
2021-04-12
Survey response — 3 months, dose 2MedDRA: Cough, Oropharyngeal pain, Sneezing — Feeling: FairFree text: Mild Cough, sore throat, sneezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-12
-
2021-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-22
- 2021-10-27
- 2021-11-03
- 2021-11-11
-
2021-12-29
Survey response — 3 months, dose 3MedDRA: Cough, Respiratory tract congestion — Feeling: GoodFree text: Intermittent cough and congestion; resolved for 3 weeks; resolved with allergy medicationsMedDRA releases: 2024-11 · check-in free text available
- 2022-03-30
-
2022-09-30
Survey response — 12 months, dose 3MedDRA: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Sneezing — Feeling: GoodFree text: Mild sneezing/runny nose 5/28-30/22 while in (b)(6)- tested positive for COVID on 6/7/22 when trying to leave (b)(6) to fly home (had been asymptomatic after 5/30). runny nose/sore throat 9/8-10/22; negative for COVID. Last booster: 9/25/22MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | Flu |
Free text
Release 1 — day 14, dose 1
Symptoms: Very mile cough just on evening of 1/2/21 and again on 1/3/21 evening; resolved today.
Release 7 — 3 months, dose 2
Symptoms: Mild Cough, sore throat, sneezing
Release 10 — 3 months, dose 3
Symptoms: Intermittent cough and congestion; resolved for 3 weeks; resolved with allergy medications
Release 12 — 12 months, dose 3
Symptoms: Mild sneezing/runny nose 5/28-30/22 while in (b)(6)- tested positive for COVID on 6/7/22 when trying to leave (b)(6) to fly home (had been asymptomatic after 5/30). runny nose/sore throat 9/8-10/22; negative for COVID. Last booster: 9/25/22
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release